
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.960 | 1.960 | 0.000 |
Stocks | 98.040 | 98.040 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.328 | 17.652 |
Price to Book | 5.880 | 3.315 |
Price to Sales | 2.945 | 2.154 |
Price to Cash Flow | 17.057 | 13.941 |
Dividend Yield | 2.775 | 2.951 |
5 Years Earnings Growth | 7.078 | 14.041 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 36.130 | 30.921 |
Industrials | 19.800 | 16.393 |
Consumer Defensive | 14.350 | 12.577 |
Financial Services | 11.820 | 20.937 |
Basic Materials | 10.910 | 8.298 |
Consumer Cyclical | 4.220 | 5.329 |
Technology | 2.770 | 3.505 |
Number of long holdings: 23
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 14.07 | 89.04 | +0.50% | |
Roche Holding Participation | CH0012032048 | 12.35 | 307.30 | +3.64% | |
Novartis | CH0012005267 | 10.89 | 96.31 | +0.64% | |
Zurich Insurance Group | CH0011075394 | 7.41 | 598.80 | +1.01% | |
ABB | CH0012221716 | 6.71 | 49.37 | +1.06% | |
Lonza Group | CH0013841017 | 6.46 | 539.20 | +0.97% | |
Givaudan | CH0010645932 | 6.16 | 4,067.00 | +2.11% | |
Sika | CH0418792922 | 4.54 | 230.70 | +1.41% | |
Partners Group | CH0024608827 | 4.18 | 1,279.50 | +0.79% | |
VAT Group | CH0311864901 | 3.24 | 337.40 | +1.02% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BCV PENSION 25 AP | 881.09M | 1.14 | 1.27 | 1.90 | ||
BCV PENSION 40 AP | 634.31M | 2.34 | 2.23 | 3.29 | ||
Synchrony All Caps CH I | 597.5M | 7.06 | -0.94 | 8.55 | ||
Synchrony Small Mid Caps CH I | 226.18M | 4.14 | -3.67 | 7.58 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review